申请人:Kali-Chemie Pharma GmbH
公开号:US04912113A1
公开(公告)日:1990-03-27
3,7-Diazabicyclo[3,3,1]nonane compounds having valuable heart rate-affecting pharmacological properties corresponding to the Formula I: ##STR1## wherein R.sup.1 is alkyl, cycloalkylalkyl or benzyl, R.sup.2 is lower alkyl, R.sup.3 is lower alkyl, or R.sup.2 and R.sup.3 together form an alkylene chain, and R.sup.4 represents a benzhydryl group, optionally substituted by halogen, lower alkoxy, lower alkyl, hydroxy or trifluoromethyl, or a cinnamyl group optionally substituted by halogen, lower alkyl, lower alkoxy, hydroxy, nitro or trifluoromethyl.
具有有价值的影响心率药理学特性的3,7-二氮杂双环[3,3,1]壬烷类化合物,对应于公式I:
##STR1##
其中R1是烷基、环烷基烷基或苄基,R2是低碳基,R3是低碳基,或者R2和R3一起形成一个烷基链,而R4代表苯基乙酰基基团,可选地被卤素、低碳氧基、低烷基、羟基或三氟甲基取代,或者是一个肉桂基,可选地被卤素、低碳基、低碳氧基、羟基、硝基或三氟甲基取代。